|  Help  |  About  |  Contact Us

Publication : Correction of a genetic disease in mouse via use of CRISPR-Cas9.

First Author  Wu Y Year  2013
Journal  Cell Stem Cell Volume  13
Issue  6 Pages  659-62
PubMed ID  24315440 Mgi Jnum  J:204144
Mgi Id  MGI:5529718 Doi  10.1016/j.stem.2013.10.016
Citation  Wu Y, et al. (2013) Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9. Cell Stem Cell 13(6):659-62
abstractText  The CRISPR-Cas9 system has been employed to generate mutant alleles in a range of different organisms. However, so far there have not been reports of use of this system for efficient correction of a genetic disease. Here we show that mice with a dominant mutation in Crygc gene that causes cataracts could be rescued by coinjection into zygotes of Cas9 mRNA and a single-guide RNA (sgRNA) targeting the mutant allele. Correction occurred via homology-directed repair (HDR) based on an exogenously supplied oligonucleotide or the endogenous WT allele, with only rare evidence of off-target modifications. The resulting mice were fertile and able to transmit the corrected allele to their progeny. Thus, our study provides proof of principle for use of the CRISPR-Cas9 system to correct genetic disease.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression